论文部分内容阅读
目的分析脾氨肽在小儿支原体肺炎治疗中的价值及对相关细胞因子的影响。方法将2010年2月-2013年1月我院小儿支原体肺炎患者68例分为两组,观察组使用克拉霉素联合脾氨肽,对照组单独使用克拉霉素,观察两组疗效及对细胞因子(IL-4、IL-10、IFN-γ)的影响。结果观察组有效率显著高于对照组;观察组IL-4低于对照组,IL-10和IFN-γ均高于对照组。结论脾氨肽通过调节免疫功能从而有效治疗小儿支原体肺炎。
Objective To analyze the value of splenic ammonia peptide in the treatment of children with mycoplasma pneumonia and its influence on related cytokines. Methods 68 patients with mycoplasma pneumonia in our hospital from February 2010 to January 2013 were divided into two groups. The observation group received clarithromycin combined with splenic ammonia and the control group received clarithromycin alone. Factor (IL-4, IL-10, IFN-γ). Results The effective rate of the observation group was significantly higher than that of the control group. IL-4 in the observation group was lower than that in the control group, and the levels of IL-10 and IFN-γ in the observation group were higher than those in the control group. Conclusions Spleen Aminopeptide can effectively treat Mycoplasma pneumonia in children by regulating immune function.